Morrison Briggs

Morrison Briggs is listed in filings as Director at CRISPR Therapeutics AG. This profile follows SEC Form 4 activity through Jun 9, 2026, including purchase activity. Recent filings connect the profile to CRISPR Therapeutics AG (CRSP), Repare Therapeutics Inc. (RPTX), Werewolf Therapeutics, Inc. (HOWL), and Carisma Therapeutics, Inc. (CARM). The current snapshot covers public activity from Jun 20, 2024 to Jun 9, 2026. Reported amounts are shown as $673.9K to $34.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.